Align Technology, Inc. $ALGN Stake Increased by TD Asset Management Inc

TD Asset Management Inc raised its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 17.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 190,120 shares of the medical equipment provider’s stock after acquiring an additional 27,830 shares during the quarter. TD Asset Management Inc owned approximately 0.26% of Align Technology worth $23,807,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Rothschild Investment LLC lifted its position in shares of Align Technology by 140.3% during the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares during the last quarter. True Wealth Design LLC lifted its holdings in Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 153 shares during the last quarter. Sentry Investment Management LLC lifted its holdings in Align Technology by 73.1% during the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 79 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Align Technology in the 2nd quarter worth approximately $36,000. Finally, MUFG Securities EMEA plc bought a new stake in shares of Align Technology in the 2nd quarter valued at approximately $38,000. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ALGN. Stifel Nicolaus lifted their price objective on shares of Align Technology from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Barclays lifted their price target on shares of Align Technology from $170.00 to $200.00 and gave the company an “equal weight” rating in a report on Wednesday. Wells Fargo & Company increased their price objective on shares of Align Technology from $181.00 to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Leerink Partners lifted their target price on Align Technology from $210.00 to $225.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley upped their target price on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $198.08.

Insider Activity at Align Technology

In related news, EVP John Morici sold 7,969 shares of Align Technology stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the sale, the executive vice president directly owned 8,237 shares in the company, valued at $1,559,346.47. The trade was a 49.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.66% of the company’s stock.

Align Technology Trading Up 0.5%

Shares of NASDAQ:ALGN opened at $190.10 on Friday. The firm’s 50 day moving average is $172.32 and its two-hundred day moving average is $151.06. The firm has a market capitalization of $13.64 billion, a P/E ratio of 33.59, a PEG ratio of 2.08 and a beta of 1.84. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $208.30.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.30. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The business had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm posted $2.44 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. Analysts predict that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.